Drug Profile
Ontazolast
Alternative Names: BIRM 270Latest Information Update: 18 Jun 2001
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim
- Class Analgesics; Anti-inflammatories; Antiallergics; Antiasthmatics; Benzoxazoles; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Leukotriene B4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 18 Jun 2001 No-Development-Reported for Asthma in Canada (Inhalation)
- 18 Jun 2001 No-Development-Reported for Asthma in Germany (Inhalation)
- 18 Jun 2001 No-Development-Reported for Asthma in USA (Inhalation)